Pregnancy follow-up registry after Exablate for fibroids
Part of Cancer clinical trials.
This study keeps track of people’s pregnancy and birth outcomes after having Exablate treatment for symptomatic uterine fibroids. It may help doctors understand how safe and effective the treatment can be for future pregnancy plans.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had uterine fibroids that caused symptoms
- You were treated with the Exablate system for your fibroids
- You are willing to join the registry (sign the consent form)
- You fit the Exablate device’s usual “indication” for symptomatic fibroids
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how uterine fibroids affect pregnancy in women. It may help doctors understand the link between fibroids and fertility.
This trial uses special contrast-enhanced ultrasound (CEUS and SHAPE) to take detailed images of uterine fibroids before and after a procedure called uterine artery embolization (UAE). It aims to help doctors better understand how fibroids respond to treatment.
This trial is a real-world registry that follows people with Parkinson’s who are planning to get an Exablate 4000 procedure (a focused ultrasound treatment) for one-sided symptoms that are difficult to control with medication. It mainly checks outcomes and safety over time, helping doctors understand how well this treatment works in everyday care.
This study collects health information from people with Fabry disease and specifically from pregnant people with Fabry disease. It helps researchers better understand the condition and how pregnancy affects health, using information you already experience in routine care.
This study aims to develop and test a tool that predicts whether uterine fibroids affect a woman's ability to get pregnant. By joining, you help doctors better understand how fibroids impact fertility and improve future care for women like you.
This study follows people who are getting an Exablate procedure to treat medication-resistant, tremor-dominant Parkinson’s. It aims to track safety and outcomes in real-world care after the treatment is approved.
Hear when a new Uterine Fibroid trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.